GH
$177.80+1.75%
as of close, Oct 2, 2026
☾ AH $177.80 +1.75%
Guardant Health Inc.Stock · Health CareNasdaq Composite 0.04%Russell 1000 0.03%Russell 3000 0.03%US Stock Market 0.03%
GH — Guardant Health Inc. price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
VolumeEEEE
20.040.060.080.0100.0120.0140.0160.0020.0M$177.80—20182020202220242026
2026-10-02
Price$177.80
MA20$153.24
MA50$118.38
Vol6.8M
Key stats
Price data
- Price
- $177.80
- Change YTD
- +74.07%
- Next earnings
- Nov 4, 2026
- Market cap
- 23.9B
- Enterprise value
- 24.5B
- Shares outstanding
- 134.2M
- 52W low
- $60.45
- 52W high
- $183.51
- From 52W high
- -3.11%
- From 52W low
- +194.13%
- 52W range
- 95%
- Beta
- 1.57
Volume
- Rel volume
- 0.91×
- 30D volume
- 1.8M
- 30D $ vol
- 310.6M
Insider trading
- Insider net 1W
- none
- Insider net 1M
- −$3.3M
- Insider net 3M
- −$30.7M
- Insider net 1Y
- −$129.1M
Form 4 transactions by trade date, as filed; latest on file 2026-09-16.
Fundamentals
- Sales (ttm)
- 1.2B
- Sales/share
- $8.82
- EPS (ttm)
- -$3.50
- FCF (ttm)
- -240.7M
- FCF/share
- -$1.79
- Book value/share
- -$1.66
- Net margin
- -38.33%
- ROA
- -23.71%
- Current ratio
- 4.03
Growth (CAGR, ttm) · 10Y
- Sales
- +42.78%+32.36%+29.60%+49.96%
- Shares
- +7.62%+4.47%+5.79%n/a
Per-share growth (CAGR, ttm) · 10Y
- Sales/share
- +32.67%+26.69%+22.51%n/a
- Price
- +189.50%+82.62%+10.58%n/a
- Total return
- +189.50%+82.62%+10.58%n/a
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- -50.7×
- Fwd P/E
- -449.4×
- P/S (ttm)
- 20.2×
- P/B (mrq)
- -107.1×
- EV/Sales (ttm)
- 20.7×
- FCF yield (ttm)
- -1.01%
- Buyback yield (realized, 1y)
- -7.62%
- Shareholder yield (realized, 1y)
- -7.62%
- Buyback yield (cash, ttm)
- -1.08%
- Shareholder yield (cash, ttm)
- -1.08%
Vs own 10Y history
- P/S
- 59th
- P/B
- 97th
Bar = where today’s multiple sits in GH’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return · as of 2026-10-02
1D
+1.75%
5D
+0.31%
1M
+9.04%
3M
+5.85%
YTD
+74.07%
1Y
+189.29%
5Y
+65.38%
Recent filings
- Sep 16Insider sale · Krognes Steve E. (Director) sold 6,674 shares for $1.2M at $174.46–$177.48
- Sep 16Insider sale · Azar Alex M II (Director) sold 826 shares for $145K at $175.00 under a 10b5-1 plan
- Sep 16Insider sale · Tariq Musa (Director) sold 116 shares for $20K at $175.00 under a 10b5-1 plan
- Sep 15Insider sale · Chudova Darya (Chief Technology Officer) sold 7,738 shares for $1.4M at $178.00
- Sep 11Insider sale · Kalia Kumud (Chief Information Officer) sold 4,000 shares for $632K at $158.05
Financial statements
Open full GH financials →Loading financial statements…
Related Health Care
| Ticker | Name | 1M | 1D |
|---|---|---|---|
| NVS | Novartis AG | -13.21% | -0.04% |
| NVO | Novo Nordisk A/S | -20.21% | -0.21% |
| SNY | Sanofi ADS | -10.23% | -1.84% |
| GSK | GSK plc American Depositary Shares (Each representing two Ordinary Shares) | -6.76% | -0.32% |
| NTRA | Natera Inc. | +26.20% | +0.46% |
| ARGX | argenx SE American Depositary Shares | -12.90% | -1.79% |
| TAK | Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) | -3.09% | +0.00% |
| TEVA | Teva Pharmaceutical Industries Limited American Depositary Shares | +5.44% | +0.56% |
